Analyst Ranking
Bottom 5%
#5046 out of 5266 analysts
Average Return
-4.1%
Win Rate
41%50 out of 122
Risk vs Reward
Poor
Good

Brandon Folkes's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Connect Biopharma Holdings LtdCNTB
+190.59%$0.85$2.47
2025-06-11 -
2026-05-01
Buy
Elutia IncELUT
+130.77%$1.43$3.30
2023-08-14 -
2024-08-14
Strong Buy
Trevi Therapeutics IncTRVI
+122.74%$2.77$6.17
2024-06-12 -
2025-06-12
Strong Buy
Trevi Therapeutics IncTRVI
+121.57%$6.26$13.87
2025-05-27 -
2026-05-01
Buy
Cormedix IncCRMD
+118.98%$6.27$13.73
2024-08-25 -
2025-08-25
Strong Buy

Brandon Folkes Analyst Color

Get additional color on Brandon Folkes's coverage of popular stocks

Brandon Folkes's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Eupraxia Pharmaceuticals IncEPRX
6Buy$11.00+39.42%Reiterates
11 days ago
Achieve Life Sciences IncACHV
4Buy$12.00+173.97%Reiterates
17 days ago
Sintx Technologies IncSINT
1Buy$10.00+314.94%Initiates Coverage On
20 days ago
Rani Therapeutics Holdings IncRANI
5Buy$11.00+1,070.21%Reiterates
a month ago
Journey Medical CorpDERM
3Buy$13.00+150.48%Reiterates
a month ago
Collegium Pharmaceutical IncCOLL
7Buy$60.00+74.83%Reiterates
a month ago
Pelthos Therapeutics IncPTHS
2Buy$60.00+140.00%Reiterates
a month ago
Sagimet Biosciences IncSGMT
3Buy$29.00+281.08%Reiterates
2 months ago
Trevi Therapeutics IncTRVI
4Buy$21.00+51.41%Reiterates
2 months ago
Xeris Biopharma Holdings IncXERS
5Buy$10.00+59.24%Reiterates
2 months ago
Mannkind CorpMNKD
9Buy$8.00+181.69%Maintains
2 months ago
Polypid LtdPYPD
5Buy$13.00+192.79%Reiterates
3 months ago
Cardiol Therapeutics IncCRDL
3Buy$9.00+556.93%Reiterates
3 months ago
Enanta Pharmaceuticals IncENTA
3Buy$20.00+39.37%Reiterates
3 months ago
Cormedix IncCRMD
5Buy$13.00+66.88%Maintains
3 months ago
Indivior Pharmaceuticals IncINDV
3Buy$48.00+27.46%Maintains
4 months ago
Heron Therapeutics IncHRTX
3Buy$6.00+372.44%Reiterates
4 months ago
Omeros CorpOMER
3Buy$40.00+165.60%Maintains
4 months ago
Milestone Pharmaceuticals IncMIST
4Buy$8.00+327.81%Reiterates
4 months ago
Traws Pharma IncTRAW
1Buy$8.00+436.91%Initiates Coverage On
5 months ago
Genfit SaGNFTY
2Buy$7.00+44.33%Maintains
7 months ago
Rein Therapeutics IncRNTX
1Buy$10.00+870.87%Initiates Coverage On
7 months ago
Ani Pharmaceuticals IncANIP
5Buy$121.00+50.52%Maintains
8 months ago
Valneva SeVALN
2Buy$18.00+236.45%Reiterates
8 months ago
Connect Biopharma Holdings LtdCNTB
2Buy$7.00+183.40%Reiterates
9 months ago
Zevra Therapeutics IncZVRA
1Buy$26.00+158.19%Initiates Coverage On
10 months ago
Rockwell Medical IncRMTI
1Strong Buy$5.00N/AInitiates Coverage On
a year ago
Adial Pharmaceuticals IncADIL
1Strong Buy$200.00N/AInitiates Coverage On
a year ago
Emergent Biosolutions IncEBS
4Strong Buy$16.00N/AReiterates
2 years ago
Scilex Holding CoSCLX
1Strong Buy$455.00N/AInitiates Coverage On
2 years ago
Sanara Medtech IncSMTI
4Strong Buy$59.00N/AReiterates
3 years ago
Jazz Pharmaceuticals PLCJAZZ
2Strong Buy$180.00N/AReiterates
3 years ago
Elutia IncELUT
3Strong Buy$8.00N/AReiterates
3 years ago
Amryt Pharma PLCAMYT
2Hold$14.75N/ADowngrades
3 years ago
Veru IncVERU
3Strong Buy$220.00N/AMaintains
3 years ago
Sorrento Therapeutics IncSRNEQ
1Strong Buy$5.00N/AInitiates Coverage On
4 years ago
Obseva SaOBSVF
1Strong Buy$6.00N/AInitiates Coverage On
4 years ago
Alkermes PLCALKS
1Strong Buy$32.00N/AUpgrades
4 years ago
IMV IncIMVIQ
1Strong Buy$40.00N/AInitiates Coverage On
5 years ago
Redhill Biopharma LtdRDHL
1Strong Buy$22,000.00N/AInitiates Coverage On
5 years ago
Trevena IncTRVN
1Strong Buy$3,125.00N/AInitiates Coverage On
6 years ago
Optinose IncOPTN
3Strong Buy$315.00N/AReiterates
6 years ago
Eagle Pharmaceuticals IncEGRX
2Hold$46.00N/AMaintains
6 years ago
Momenta Pharmaceuticals IncMNTA
1Hold$30.00N/AReiterates
6 years ago
Opiant Pharmaceuticals IncOPNT
1Strong Buy$42.00N/AMaintains
8 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
1Strong Buy$50.00N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.